Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRSF3 pseudogene 6 (SRSF3P6) is a genomic sequence classified as a pseudogene and is related to the serine/arginine-rich splicing factor 3 (SRSF3) gene. Pseudogenes like SRSF3P6 arise from gene duplication or retrotransposition events and typically lack protein-coding function. Consequently, SRSF3P6 itself is not a therapeutic or molecular target, does not have known biological activity, and is not associated with any characterized disease roles or pharmacological interactions. The canonical SRSF3 is a well-studied transcriptional and splicing regulator involved in oncogenesis and various cellular processes[1][2][3]. However, SRSF3P6 itself is not a protein-coding gene and should not be confused with its functional parental gene SRSF3. SRSF3P6 is a pseudogene and not a therapeutic target. Any associations, drug interactions, or disease roles pertain to the parental gene SRSF3 (SRp20), not the pseudogene[2][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRSF3 pseudogene 6 (SRSF3P6).